Johan Hansson

7.2k total citations
151 papers, 4.8k citations indexed

About

Johan Hansson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Johan Hansson has authored 151 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 52 papers in Molecular Biology and 50 papers in Immunology. Recurrent topics in Johan Hansson's work include Cutaneous Melanoma Detection and Management (59 papers), Immunotherapy and Immune Responses (38 papers) and Melanoma and MAPK Pathways (25 papers). Johan Hansson is often cited by papers focused on Cutaneous Melanoma Detection and Management (59 papers), Immunotherapy and Immune Responses (38 papers) and Melanoma and MAPK Pathways (25 papers). Johan Hansson collaborates with scholars based in Sweden, United Kingdom and Germany. Johan Hansson's co-authors include Rolf Kiessling, Giuseppe Masucci, Isabel Poschke, Ulrik Ringborg, Dimitrios Mougiakakos, Lars Bastholt, Ulrika Stierner, Steinar Aamdal, Yago Pico de Coaña and Lena Kanter‐Lewensohn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Johan Hansson

148 papers receiving 4.7k citations

Peers

Countries citing papers authored by Johan Hansson

Since Specialization

Citations

This map shows the geographic impact of Johan Hansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Hansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Hansson more than expected).

Fields of papers citing papers by Johan Hansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Hansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Hansson. The network helps show where Johan Hansson may publish in the future.

Co-authorship network of co-authors of Johan Hansson

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Hansson. A scholar is included among the top collaborators of Johan Hansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Hansson. Johan Hansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in Melanoma 2021 ·Journal of Investigative Dermatology ·Ishani Das, Rainer Tuominen, Thomas Helleday, Johan Hansson, Ulrika Warpman Berglund, Suzanne Egyházi Brage	6
2	TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma 2020 ·BMC Cancer ·(unknown), Hildur Helgadóttir, Yvonne Brandberg, Johan Hansson, Roger Olofsson Bagge, Nils Elander, Christian Ingvar, Karolin Isaksson, Petra Flygare, Cecilia Nilsson, (unknown), (unknown), Antonis Valachis, (unknown), (unknown), Lars Ohlsson, (unknown), (unknown), Anders Sundin, Gustav Ullenhag	8
3	OpACIN-neo: A multicenter phase II study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO) 2018 ·Annals of Oncology ·Christian U. Blank, Elisa A. Rozeman, Alexander M. Menzies, Bart A. van de Wiel, Chandra Mani Adhikari, Karolina Sikorska, Oscar Krijgsman, Hanna Eriksson, Carolien Bierman, Lindsay G. Grijpink-Ongering, Maria Gonzalez, Annegien Broeks, Alexander Guminski, Andrew J. Spillane, W. Martin C. Klop, Robyn P.M. Saw, Richard A. Scolyer, Alexander C. J. van Akkooi, Johan Hansson, Georgina V. Long	12
4	Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma 2017 ·International Journal of Cancer ·(unknown), Johan Hansson, Sandra Eloranta, Max Gordon, Peter Gillgren, Karin E. Smedby	7
5	VEGF-A Expression Correlates with TP53 Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy 2015 ·Cancer Research ·Maria Schwaederlé, Vladimir Lazar, Pierre Validire, Johan Hansson, (unknown), Jean‐Charles Soria, Yudi Pawitan, Razelle Kurzrock	96
6	Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial 2015 ·Cancer Immunology Immunotherapy ·Lina Prasmickaite, G Berge, (unknown), Steinar Aamdal, Johan Hansson, Lars Bastholt, (unknown), Kjetil Boye, Gunhild M. Mælandsmo	5
7	Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men 2014 ·British Journal of Dermatology ·Johan Lyth, Hanna Eriksson, Johan Hansson, Christian Ingvar, (unknown), Jan Lapins, Eva Månsson‐Brahme, Peter Naredi, Ulrika Stierner, Gustav Ullenhag, John Carstensen, C. Lindholm	30
8	Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial 2014 ·Trials ·Roger Olofsson Bagge, Lars Ny, Malin Sternby Eilard, Magnus Rizell, Christian Cahlin, Ulrika Stierner, Ulf Lönn, Johan Hansson, Ingrid Ljuslinder, Lotta Lundgren, Gustav Ullenhag, Jens Folke Kiilgaard, Jonas A. Nilsson, Per Lindnér	29
9	Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production 2013 ·Cancer Immunology Research ·Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe Masucci, Rolf Kiessling	110
10	KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma 2013 ·Journal of Dermatological Science ·(unknown), Katarina Omholt, Ismini Vassilaki, Veronica Höiom, (unknown), (unknown), Lena Kanter‐Lewensohn, Carolina Johansson, Johan Hansson	71
11	Hereditary uveal melanoma: A report of a germline mutation in BAP1 2013 ·Genes Chromosomes and Cancer ·Veronica Höiom, Daniel Edsgärd, Hildur Helgadóttir, Hanna Eriksson, Charlotta All‐Ericsson, Rainer Tuominen, Ivayla Ivanova, Joakim Lundeberg, Olof Emanuelsson, Johan Hansson	40
12	Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark’s level of invasion: results of a population-based study from the Swedish Melanoma Register 2012 ·British Journal of Dermatology ·Johan Lyth, Johan Hansson, Christian Ingvar, Eva Månsson‐Brahme, Peter Naredi, Ulrika Stierner, Gunnar Wagenius, C. Lindholm, (unknown)	33
13	KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites 2011 ·Clinical Cancer Research ·Katarina Omholt, (unknown), Lena Kanter‐Lewensohn, Johan Hansson, Boel Ragnarsson-Olding	135
14	Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial 2011 ·The Lancet Oncology ·Johan Hansson, Steinar Aamdal, Lars Bastholt, Yvonne Brandberg, Micaela Hernberg, Bo Nilsson, Ulrika Stierner, Hans von der Maase	66
15	Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign 2010 ·Cancer Research ·Isabel Poschke, Dimitrios Mougiakakos, Johan Hansson, Giuseppe Masucci, Rolf Kiessling	329
16	Meeting Report of the Conference on UV-Radiation-Induced Disease—Roles of UVA and UVB 2008 ·Journal of Investigative Dermatology ·J. M. Emeny, Johan Hansson, Rune Toftgård, Dan Segerbäck	1
17	Invasive cutaneous malignant melanoma in Sweden, 1990–1999 2004 ·Cancer ·Christer Lindholm, (unknown), Monika Dufmats, Johan Hansson, Christian Ingvar, Henrik Møller, Helena Sjödin, Ulrika Stierner, Gunnar Wagenius, (unknown)	83
18	High‐Dose Cisplatin With Amifostine: Ototoxicity and Pharmacokinetics 2004 ·The Laryngoscope ·(unknown), Johan Hansson, Hans Ehrsson, Staffan Eksborg, Inger Wallin, Gunnar Wagenius, Göran Laurell	29
19	Antibody-targeted superantigens in cancer immunotherapy 1996 ·Immunotechnology ·Morten Søgaard, Johan Hansson, Mark J. Litton, Lennart Ohlsson, Alexander Rosendahl, Peter A. Lando, Per Antonsson, Terje Kalland, Mikael Dohlsten	6
20	Estramustine binding protein in primary tumours and metastases of malignant melanoma 1994 ·Melanoma Research ·E. von Schoultz, (unknown), Roger Henriksson, (unknown), Johan Hansson	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact